Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04369469 |
|---|---|
| Brief Title: | Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia |
| First Submitted : | April 28, 2020 |
| First Submitted that Met QC Criteria : | April 28, 2020 |
| First Posted : | April 30, 2020 |
| Last Update Submitted that Met QC Criteria : | February 2, 2021 |
| Last Update Posted : | February 3, 2021 |